Drug Type Therapeutic vaccine, Dendritic cell vaccine |
Synonyms MIDRIX4-LUNG |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
metastatic non-small cell lung cancer | Phase 1 | Belgium | 26 Aug 2019 |
Phase 1 | 6 | rsthowivav(hdhhwqgjut) = dizziness (N=3), fatigue (N=3), nausea (N=2) and flu-like symptoms (N=2). tzrbqgxsha (uupcsaxcsj ) | Positive | 26 Mar 2025 |